Pharmaceutical compounds
US10882829B2 · kind B2 · utility
2Cited by
4References
2Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 13, 2019 |
| Grant date | Jan 5, 2021 |
| Priority date | — |
| Expiry date | Mar 13, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a method of inhibiting a TYK2 kinase, which method comprises bringing into contact with the TYK2 kinase an effective TYK2 kinase-inhibiting amount of a compound having the formula (0): or a salt or stereoisomer thereof. The invention also provides a novel subset of compounds within formula (0) as well as pharmaceutical compositions containing them and their use in medicine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.